RxDoctor Payments DataLook up a doctor →

Nicole Misiaszek

Medical · Enfield, CTNPI 1770772063

Payments from drug & device makers

$13,679in general payments, 2019–2025

Across 738 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • GSK$1K
  • Lilly USA, LLC$962
  • AstraZeneca$908
  • Boehringer Ingelheim$682
  • plus $6K from 47 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie180$2,795
Novo Nordisk87$1,539
GSK65$1,166
Lilly USA, LLC46$962
AstraZeneca(2 entities)36$908
Boehringer Ingelheim31$682
Pfizer39$642
Amgen15$313
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC17$302
Otsuka America Pharmaceutical, Inc.16$282
Lundbeck LLC13$280
Paratek Pharmaceuticals, Inc.12$209
Exact Sciences11$208
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$208
Biohaven Pharmaceutical Holding Company Ltd.18$186
Azurity Pharmaceuticals, Inc.8$177
Abbott8$162
Impel Pharmaceuticals Inc.9$159
E.r. Squibb & Sons, L.L.C.6$150
Regeneron Healthcare Solutions, Inc.6$139
Indivior Inc.5$133
Takeda Pharmaceuticals U.S.A., Inc.6$129
Antares Pharma, Inc.6$126
Corium, LLC9$125
Sumitomo Pharma America, Inc.5$123
Sanofi-aventis U.S. LLC6$118
Amarin Pharma, Inc.6$116
Novartis6$114
Phathom Pharmaceuticals, Inc.5$111
Kowa Pharmaceuticals America, Inc.7$103
Johnson & Johnson(2 entities)2$82
Idorsia Pharmaceuticals US Inc5$76
Corcept Therapeutics3$66
Bayer3$65
Orthofix Medical, Inc.1$63
Eisai Inc.3$54
Biohaven Pharmaceuticals, Inc.2$53
Actelion Pharmaceuticals US, Inc.2$53
Ardelyx, Inc.3$51
Currax Pharmaceuticals LLC3$49
Braeburn Inc.2$47
Scilex Pharmaceuticals Inc.2$45
Sanofi2$42
Halozyme Inc2$38
Merck2$38
Teva Pharmaceuticals USA, Inc.2$37
Inspire Medical Systems, Inc.1$36
Axsome Therapeutics, Inc.1$33
Bausch Health US, LLC1$23
Adlon Therapeutics L.p.1$22
Collegium Pharmaceutical, Inc.1$17
Echosens North America, Inc.1$12
Arbor Pharmaceuticals, Inc.1$12

How this compares

$13,679 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut →

Medicare billing

Part B allowed, 2024
$54,559
Medicare patients
131
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Enfield

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →